HDAC9 and chronic kidney disease: Intriguingly, TSA prevented Klotho loss by increasing the promoter-associated histone acetylation, therefore increasing Klotho transcription, suggesting the therapeutic potentials of endogenous Klotho restoration by HDAC inhibition in treating CKD and other complications [41].